Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminatomous testicular cancer
Bokkel Huinink, ten, W.W.
Faculty of Medicine and Health Sciences
The British journal of cancer. - London
, p. 432-435
University of Antwerp